Regarding the mechanism of action, is the GLP-1RA reducing lymphedema because of the induced weight loss or is there another mechanism at play
Injectable GLP-1s may be more suitable for: Patients aiming for the maximum possible reduction in body weight, those with co-existing conditions like heart disease or chronic kidney disease (due to specific FDA approvals for Ozempic), or those who prefer a simple weekly medication schedule
If you are tracking your progress with before and after documentation , note your injection sites alongside your results
What is Glutathione IV
Safe Use, Mitigation Strategies, and When to Consult Your Provider To minimize glutathione depletion risk: stay within recommended dosing limits (maximum 3,0004,000 mg/day for adults), avoid chronic daily use without medical guidance, maintain adequate nutrition (protein, vitamins B6 and C support glutathione synthesis), and consider alternatives like physical therapy or NSAIDs where appropriate
Retatrutide acts as a triple agonist targeting GIP, GLP-1, and glucagon receptors, producing weight loss averaging 24.2% in clinical trials